Mosaic ImmunoEngineering CPMV
OTC CPMV
$0.06 +0.00 (+0.00%)
As of: Oct 21, 2026 · 11:47 AM EDT

Mosaic ImmunoEngineering (CPMV) Change in Receivables (2010 - 2011)

Updated

Mosaic ImmunoEngineering's Change in Receivables was -$86,330 in Q2 2012, compared with $83,200 a year earlier.

Analysis

Mosaic ImmunoEngineering (CPMV) Change in Receivables (2010 - 2011) Analysis & Trends

On a trailing twelve-month basis, Mosaic ImmunoEngineering's Change in Receivables was $150,383 through Nov 30, 2011.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change Receivables (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn -
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 1.35 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 1.37 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn -
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn -
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 1.09 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 333.00 Mn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -
10 Mosaic ImmunoEngineering 441,423.27 352,385.27 - -
Historic Data

Historic Data

Download Data
DateValue
Nov 30, 2011 -86,330.00
Aug 31, 2011 160,009.00
Nov 30, 2010 83,200.00
Aug 31, 2010 -6,496.00
API Access

Mosaic ImmunoEngineering Change in Receivables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=change-in-receivables&ticker=CPMV&period=max&api_key=YOUR_API_KEY